The headline for the story in the Wall Street Journal by Jonathan Rockoff said it all: Pfizer to Pay Academics to Find Uses for Molecules.
Rather than have their own researchers take a crack at it, Pfizer is spending $22.5M to have researchers at the medical school at Washington University in St. Louis review approximately 500 Pfizer molecules to see if they can be used for other purposes than those for which were either approved, or are in current research for a different use, or failed in clinical trials.… Read the rest